IL6 and neoplasm: Rajasekar et al. concluded that diosmin (at a daily dose of 100 mg/kg bw) suppressed cellular proliferation and tumor progression in 7,12-dimethylbenz(a)anthracene- (DMBA-) induced hamster buccal pouch carcinoma through inhibition of the IL-6/STAT3 signaling pathway [56].